---
layout: post
title: "Announcement of the Re-Approval of AABB (Association for the Advancement of Blood and Biotherapies) as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988"
date: 2026-02-05 19:09:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-08809
original_published: 2024-04-25 00:00:00 +0000
significance: 8.00
---

# Announcement of the Re-Approval of AABB (Association for the Advancement of Blood and Biotherapies) as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 25, 2024 00:00 UTC
**Document Number:** 2024-08809

## Summary

This notice announces the application of the Association for the Advancement of Blood and Biotherapies (AABB) for re-approval as an accreditation organization for clinical laboratories under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) program. This deeming authority is granted to AABB for the Blood Bank and Transfusion Service (BB/TS) program, the Immunohematology Reference Laboratory (IRL) program, the Molecular Testing (MT) program, and the Cellular Therapy (CT) program. We have determined that AABB meets or exceeds the applicable CLIA requirements. We are announcing the re-approval and grant AABB deeming authority for a period of 6 years.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/04/25/2024-08809/announcement-of-the-re-approval-of-aabb-association-for-the-advancement-of-blood-and-biotherapies-as)
- API: https://www.federalregister.gov/api/v1/documents/2024-08809

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
